Is 7.8% Drug Cost Cut Justifiable? Make “Huge Seller” Re-Pricing a Starter to Discuss This

The Central Social Insurance Medical Council (Chuikyo) on December 25 approved a list of plans for the FY2016 drug pricing reform next April. While the pharma industry won the health ministry’s commitment to crafting a long-demanded price maintenance rule for...read more